Common viruses trigger most cases of intussusception in children, suggests study Dr. Kamal Kant Kohli2 April 2024 7:30 PM ISTViral infections trigger more cases of intussusception, the common cause of bowel blockages in young children, than previously thought, according...
AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants Ruchika Sharma31 March 2024 12:30 PM ISTCambridge: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of...
Sanofi Gets CDSCO Panel Nod To Import, Market Nirsevimab to Treat Respiratory Syncytial Virus Disease Dr. Divya Colin27 March 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Sanofi Healthcare India has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Nirsevimab found Effective in Preventing RSV-Associated Hospitalizations Among Infants in new research Dr.Niharika Harsha B11 March 2024 12:45 AM ISTIn a significant development in pediatric healthcare, nirsevimab, a long-acting monoclonal antibody, has demonstrated robust real-world...
Understanding RSV Infection in Children: Symptoms, Diagnosis and Prevention - Dr Srinivas Jakka Dr Srinivas Jakka6 March 2024 3:38 PM IST Introduction Respiratory syncytial virus, or RSV, is one of the most common viruses causing respiratory infection across the world. Many...
Pfizer Gets CDSCO Panel Nod to Study Sisunatovir in Adults With Respiratory Syncytial Virus Infection Dr. Divya Colin18 Jan 2024 6:00 PM ISTNew Delhi: The drug major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intranasal Palivizumab Fails to Prevent RSV Infection in Preterm Babies Jacinthlyn Sylvia4 Jan 2024 7:00 PM ISTA recent double-blind, randomized placebo-controlled trial found that daily intranasal palivizumab, a mucosal monoclonal antibody (mAb) did not...
AstraZeneca-Sanofi Beyfortus gets nod for RSV disease prevention in infants in China Ruchika Sharma2 Jan 2024 3:06 PM ISTChina: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of...
Nirsevimab effective in preventing hospitalization for RSV associated lower RTI in infants Aditi29 Dec 2023 7:00 PM ISTRespiratory syncytial virus (RSV) is a common cause of lower respiratory tract infection in young children and infants, leading to...
Preventive therapy for RSV: AstraZeneca India gets CDSCO nod for Palivizumab injection Ruchika Sharma3 Oct 2023 2:30 PM ISTNew Delhi: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, has announced the marketing approval from Central Drugs Standard...
Live-Attenuated RSV Vaccine Shows Immunogenicity in Children: Journal of Infectious Diseases Jacinthlyn Sylvia21 Sept 2023 10:15 AM ISTRespiratory syncytial virus (RSV) is a significant cause of lower respiratory illness (LRI) in pediatric populations. With the need for an effective...
First Vaccine for Pregnant Individuals to Prevent RSV in Infants approved by FDA Dr. Kamal Kant Kohli22 Aug 2023 12:00 PM ISTRespiratory Syncytial Virus is a highly contagious virus that causes respiratory infections in individuals of all age groups. Furthermore it is the...
